Glatiramer
Links shared publicly online about this topic
ingentaconnect Glatiramer Acetate in the Treatment of Multiple Sclerosis: Emergi...
ingentaconnect.com — “ingentaconnect Glatiramer Acetate in the Treatment of Multiple Sclerosis: Emergi...” View full resource at ingentaconnect.com
Most Recently Shared on April 13, 2011 at 4:49 am By:
Glatiramer Acetate in the Treatment of Multiple Sclerosis: Emerging Concepts Regarding its Mechanism of Action: ... http://bit.ly/fxStFB
Early Treatment With Glatiramer Acetate Improved Outcomes in CIS : Internal Medicine News
internalmedicinenews.com — “Early Treatment With Glatiramer Acetate Improved Outcomes in CIS : Internal Medicine News” View full resource at internalmedicinenews.com
Most Recently Shared on October 25, 2010 at 6:00 pm By:
Bob Finn - Medical News Net Health News
Early Treatment With Glatiramer Acetate Improved Outcomes in Clinically Isolated Syndrome http://bit.ly/aL95V3
Interferon -1b and glatiramer acetate effects on permanent black hole evolution
neurology.org — “Interferon -1b and glatiramer acetate effects on permanent black hole evolution” View full resource at neurology.org
Most Recently Shared on April 5, 2011 at 9:42 pm By:
Neurology Journal Medical Journal and Neurology
Interferon -1b and glatiramer acetate effects on permanent black hole evolution http://bit.ly/htqcYO #neurology
Teva Completes Enrollment In Phase III Multiple Sclerosis Trial Evaluating Glatiramer Acetate Three Times Weekly
medicalnewstoday.com — “Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced completion of patient enrollment for the GALA (Glatiramer Acetate Low-frequency Administration) trial. This international Phase I” View full resource at medicalnewstoday.com
Most Recently Shared on June 3, 2011 at 4:05 pm By:
Teva Completes Enrollment In Phase III Multiple Sclerosis Trial Evaluating Glatiramer Acetate Three Times Weekly: Teva.. http://dld.bz/acfdG
ingentaconnect Long-Term Use of Glatiramer Acetate by 11 Pregnant Women with Mul...
ingentaconnect.com — “ingentaconnect Long-Term Use of Glatiramer Acetate by 11 Pregnant Women with Mul...” View full resource at ingentaconnect.com
Most Recently Shared on October 11, 2010 at 2:59 pm By:
Long-Term Use of Glatiramer Acetate by 11 Pregnant Women with Multiple Sclerosis: A Retrospective, Multicentre Cas... http://bit.ly/bTfkam
IngentaConnect Glatiramer Acetate: A Review of its Use in Relapsing-Remitting Mu...
ingentaconnect.com — “IngentaConnect Glatiramer Acetate: A Review of its Use in Relapsing-Remitting Mu...” View full resource at ingentaconnect.com
Most Recently Shared on August 8, 2010 at 10:41 am By:
Glatiramer Acetate: A Review of its Use in Relapsing-Remitting Multiple Sclerosis and in Delaying the Onset of Cli... http://bit.ly/cpYVBM
ingentaconnect Long-Term Use of Glatiramer Acetate by 11 Pregnant Women with Mul...
ingentaconnect.com — “ingentaconnect Long-Term Use of Glatiramer Acetate by 11 Pregnant Women with Mul...” View full resource at ingentaconnect.com
Most Recently Shared on October 12, 2010 at 3:38 am By:
Long-Term Use of Glatiramer Acetate by 11 Pregnant Women with Multiple Sclerosis: A Retrospective, Multicentre Cas... http://bit.ly/aSL3gd
ECTRIMS: Early Glatiramer Cuts MS Conversion Rate (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- GOTHENBURG, Sweden -- Early treatment with glatiramer (Copaxone) proved superior to later treatment in reducing conversion to definite multiple sclerosis in patients with a clinically isolated syndrome, researchers said here.” View full resource at qualitypointtech.net
Most Recently Shared on October 17, 2010 at 12:01 am By:
ECTRIMS: Early Glatiramer Cuts MS Conversion Rate (CME/CE): (MedPage Today) -- GOTHENBURG, Sweden -- Early treatme... http://bit.ly/bvUNmk
ECTRIMS: Glatiramer Acetate Beats Interferon for MS Fatigue (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- GOTHENBURG, Sweden"Glatiramer acetate acetate reduces MS fatigue after 1 year more than interferon beta-1b, according to a study.” View full resource at qualitypointtech.net
Most Recently Shared on October 18, 2010 at 12:49 am By:
ECTRIMS: Glatiramer Acetate Beats Interferon for MS Fatigue (CME/CE): (MedPage Today) -- GOTHENBURG, Sweden—Glat... http://bit.ly/c82BxM
Glatiramer acetate for multiple sclerosis. [Cochrane Database Syst Rev. 2010] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on May 17, 2010 at 1:22 am By:
Glatiramer acetate for multiple sclerosis.: CONCLUSIONS: Glatiramer acetate did show a partial efficacy in RR MS i... http://bit.ly/cvQQGf
Glatiramer acetate exposure in pregnancy: prelimin... [J Neurol. 2010] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on July 14, 2010 at 9:31 am By:
George Jelinek Doctor, Emergency Physician, and Physician
Glatiramer (Copaxone) appears to be safe in pregnancy http://www.ncbi.nlm.nih.gov/pubmed/20625758
Patterns of Th1/Th2 Cytokines Predict Clinical Response in Multiple Sclerosis Patients Treated with Glatiramer Acetate
content.karger.com — “The patterns of Th1/Th2 cytokines in relapsing-remitting multiple sclerosis were analyzed to evaluate their relevance as biomarkers of therapy response to glatiramer acetate (GA). Serum interferon- (IFN-), osteopontin and interleukin (IL)-2, IL-4, and IL-10 were measured in 19 relapsing-remitting multiple sclerosis patients treated with GA in a prospective study over 3 years. The quotient (IL-2 + IFN-)/(IL-4 + IL-10) was elevated in patients with relapses as compared to relapse-free patients aft” View full resource at content.karger.com
Most Recently Shared on March 3, 2011 at 11:05 am By:
Patterns of Th1/Th2 Cytokines Predict Clinical Response in Multiple Sclerosis Patients Treated with Glatiramer A... http://bit.ly/dXq5c5
MS Trial Alert: Investigators Recruiting for Study of Less Frequent Dosing of Glatiramer Acetate : National MS Society
nationalmssociety.org — “MS stops people from moving. The National MS Society exists to make sure it doesn't.” View full resource at nationalmssociety.org
Most Recently Shared on December 21, 2010 at 5:31 pm By:
News! MS Trial Alert: Investigators Recruiting for Study of Less Frequent Dosing of Glatiramer Acetate http://bit.ly/gOVkMk
Multiple Sclerosis-Associated Fatigue during Disease-Modifying Treatment with Natalizumab, Interferon-Beta and Glatiramer Acetate
content.karger.com — “No abstract available” View full resource at content.karger.com
Most Recently Shared on March 31, 2011 at 4:03 am By:
Multiple Sclerosis-Associated Fatigue during Disease-Modifying Treatment with Natalizumab, Interferon-Beta and G... http://bit.ly/hT9bUe
Medical News: CMSC: Novel MS Drug May Boost Glatiramer Efficacy - in Meeting Coverage, CMSC from MedPage Today
medpagetoday.com — “MONTREAL -- Adding the investigational, oral drug teriflunomide to glatiramer acetate (GA, Copaxone) in patients with relapsing multiple sclerosis substantially decreased the MRI lesion burden, althou” View full resource at medpagetoday.com
Most Recently Shared on June 6, 2011 at 6:29 pm By:
CMSC: Novel MS Drug May Boost Glatiramer Efficacy (CME/CE) http://bit.ly/mgy0DC
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
OrganizedWisdom MS
Organizing multiple sclerosis resources shared by health experts, advocates, and organizations into WisdomCards.
-
Bob Finn - Medical News Net
Bringing you the latest news from scientific meetings and the policy world. Check us out at www.internalmedicinenews.com
-
Neurology Journal
Advertisement
